Business Description
Galapagos NV is a Belgian biotechnology company founded in 1999 that researches and develops new treatments for cancer and immune system diseases, with operations primarily in the United States and Europe. The company currently has several drugs in clinical trials, including therapies targeting conditions such as lupus, lymphoma, and multiple myeloma. Galapagos works alongside Gilead Sciences as a key partner in advancing its research.
